Tg Therapeutics (TGTX) Other Accumulated Expenses (2018 - 2026)

Tg Therapeutics' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $596000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 79.78% year-over-year to $596000.0; the TTM figure through Mar 2026 stood at $596000.0 (down 79.78% YoY), while the FY2025 annual figure was $2.1 million, down 54.1% from the prior year.
• Other Accumulated Expenses was $596000.0 for Q1 2026 at Tg Therapeutics, down from $2.1 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $4.6 million in Q4 2024 to a low of $596000.0 in Q1 2026.
• Historically, Other Accumulated Expenses has averaged $2.2 million across 5 years, with a median of $1.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses slumped 93.61% in 2022, then surged 232.84% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $1.2 million in 2022, then climbed by 26.52% to $1.5 million in 2023, then jumped by 212.85% to $4.6 million in 2024, then sank by 54.1% to $2.1 million in 2025, then plunged by 71.94% to $596000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $596000.0 (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.